Microbiota and epigenetics: promising therapeutic approaches?

Area of Science:

• Microbiology
• Epigenetics
• Immunology

Background:

• The gut microbiome's role in disease, both within and outside the digestive tract, is extensively documented.
• Dysbiosis, or microbial imbalance, can lead to disease through various mechanisms, including immune suppression and interference with epigenetic regulation.
• Restoring microbial balance is a promising therapeutic avenue.

Purpose of the Study:

• To review the intricate interactions between the gut microbiome and epigenetics in disease pathogenesis.
• To highlight potential future therapeutic strategies for reestablishing a healthy internal micro-ecosystem.

Main Methods:

• Literature review focusing on studies investigating the gut microbiome, epigenetics, and disease.
• Analysis of various approaches for microbiome manipulation, including prebiotics, probiotics, and transplantation.
• Discussion of the interplay between microbial communities and host epigenetic mechanisms.

Main Results:

• The gut microbiome significantly impacts host health and disease development.
• Epigenetic modifications are influenced by microbial composition and activity.
• Imbalances in the gut microbiome are linked to immune system dysfunction and disease.

Conclusions:

• Modulating the gut microbiome and its epigenetic influence presents a viable therapeutic strategy.
• Future treatments may focus on restoring gut microbial equilibrium through diverse interventions.
• Understanding the microbiome-epigenetics axis is crucial for developing novel disease management approaches.